Results 101 to 110 of about 406,477 (211)

Frequency of serovars and antimicrobial resistance in Shigella spp. from Brazil

, 2017
A total of 296 Shigella spp. were received from State Public Health Laboratories, during the period from 1999 to 2004, by National Reference Laboratory for Cholera and Enteric Diseases (NRLCED) - IOC/Fiocruz, Rio de Janeiro, Brazil.
Souza, Flávia dos Santos, Rodrigues, Dalia dos Prazeres, Peirano, Gisele, Shigella Study Group   +3 more
core  

The molecular evolutionary history of Shigella spp. and enteroinvasive Escherichia coli

Infection, Genetics and Evolution, 2009
Shigellosis, which caused by Shigella and enteroinvasive Escherichia coli (EIEC), was still a threat to public health. Compelling evidence indicates that Shigella species and EIEC are derived from multiple origins of E. coli and form a single pathovar. EIEC strains are regarded as precursors of 'full-blown'Shigella evolved from E. coli.
Junping, Peng, Jian, Yang, Qi, Jin
openaire   +2 more sources

Distribution of Virulence and Antimicrobial Resistance Determinants in Shigella Spp.

, 2022
The study describes the species trends and the antimicrobial susceptibility profile of the isolates. The presence of virulence, antimicrobial resistance determinants and its associated mobile genetic elements was analyzed.
Dhiviya Prabaa, M S
core  

Shigella spp. Antimicrobial Drug Resistance, Papua New Guinea, 2000–2009 [PDF]

, 2010
Approximately half the Shigella spp. infections in developing countries are caused by endemic shigellae (1), which in these countries are responsible for ¡Ö10% of all episodes of diarrhea among ...
Rosewell, A, Glen Mola, Dutta, S, Berry Ropa, Zwi, A, Enoch Posanai, Samir R. Dutta, C. Raina MacIntyre, Mola, G, Posanai, E, MacIntyre, CR ; https://orcid.org/, Anthony Zwi, Alexander Rosewell, Ropa, B   +13 more
core   +1 more source

Prevalence, antimicrobial susceptibility test and associated factors of Salmonella and Shigella in ready-to-eat fruit juices and salads in Mekelle, northern Ethiopia

BMC Infectious Diseases
Background Food borne diseases is a challenging problem nowadays. Salmonella and Shigella species are great concern of food-born outbreaks. Thus, this study was aimed to assess the prevalence, antimicrobial susceptibility test and associated factors of ...
Tesfay Berihu, Guesh Gebremariam, Yemane Weldu, Amlsha Kahsay, Tsehaye Asmelash, Araya Gebreyesus   +5 more
doaj   +1 more source

Molecular diagnosis of non-serotypeable Shigella spp.: problems and prospects

Journal of Medical Microbiology, 2017
It is not always possible to identify Shigella serogroups/serotypes by biochemical properties alone. Specific identification requires serotyping. Occasionally, isolates that resemble Shigella spp. biochemically, but are non-agglutinable with available antisera, have been observed.
Dhiviya Prabaa, Muthuirulandi Sethuvel, Naveen Kumar, Devanga Ragupathi, Shalini, Anandan, Kamini, Walia, Balaji, Veeraraghavan   +4 more
openaire   +2 more sources

Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020. [PDF]

Emerg Infect Dis, 2022
Gaufin T, Blumenthal J, Ramirez-Sanchez C, Mehta S, Pride DT, Fierer J, Jenks JD.   +6 more
europepmc   +1 more source

Development of a recombinase polymerase amplification assay with lateral flow dipstick (RPA-LFD) for rapid detection of Shigella spp. and enteroinvasive Escherichia coli. [PDF]

PLoS One, 2022
Bian Z, Liu W, Jin J, Hao Y, Jiang L, Xie Y, Zhang H.   +6 more
europepmc   +1 more source

Vaccination with a Protective Ipa Protein-Containing Nanoemulsion Differentially Alters the Transcriptomic Profiles of Young and Elderly Mice following Shigella Infection

Vaccines
Shigella spp. are responsible for bacillary dysentery or shigellosis transmitted via the fecal–oral route, causing significant morbidity and mortality, especially among vulnerable populations. There are currently no licensed Shigella vaccines.
Ti Lu, Murugesan Raju, Debaki R. Howlader, Zackary K. Dietz, Sean K. Whittier, David J. Varisco, Robert K. Ernst, Lyndon M. Coghill, William D. Picking, Wendy L. Picking   +9 more
doaj   +1 more source

Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against <i>Shigella</i> spp. [PDF]

Front Immunol, 2023
Lu T, Das S, Howlader DR, Jain A, Hu G, Dietz ZK, Zheng Q, Ratnakaram SSK, Whittier SK, Varisco DJ, Ernst RK, Picking WD, Picking WL.   +12 more
europepmc   +1 more source